CRISPR-Cas Logic Gates for Precise Gene Expression Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for controlling gene expression lack precision and specificity, particularly in tissue-specific applications, as they often rely on complex biochemical interactions and limited scalability, making it challenging to generate precise patterns of gene expression.
Innovation Solution
A logic-gate-based system using orthogonal pairs of hybridizing synthetic nucleic acid constructs, comprising CRISPR nucleic acid and trans-activating CRISPR nucleic acid hybrids, which form complexes with Type II or Type V CRISPR-Cas effector proteins to modify gene expression, allowing for precise control through promoter-driven expression and base-pairing modifications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If complex biochemical interactions are used to control gene expression, then gene expression control is achieved, but precision and specificity are reduced
Solution Approach 1:
The system segments the gene control mechanism into discrete logic gates (AND, OR, NOT gates) that process genetic inputs through defined Boolean operations. Each logic gate is a modular unit that takes specific genetic inputs and produces a binary output, dividing the complex control problem into manageable, precise computational steps that enhance control precision while maintaining systematic complexity.
Solution Approach 2:
The invention changes the fundamental parameter of gene control from continuous biochemical gradients to discrete binary states (0 or 1, on or off). By using CRISPR-Cas systems with threshold-based activation and orthogonal nucleic acid pairs with specific binding affinities, the system transforms analog biochemical signals into digital logic states, dramatically improving control precision and specificity.
2Adaptability or versatility
If limited scalability methods are used for gene expression control, then current control capabilities are maintained, but the ability to generate precise patterns of gene expression is reduced
Solution Approach 1:
The logic gate system provides universal control mechanisms that can be applied to any gene target through programmable CRISPR guide RNAs. The same AND, OR, and NOT gate architectures can control different genes by simply changing the guide RNA sequences, making the system universally applicable while maintaining precise spatial and temporal control patterns across multiple genetic targets.
Solution Approach 2:
The system implements nested logic gates where multiple logic operations are combined hierarchically to control gene expression. For example, an outer logic gate can combine the outputs of inner logic gates, allowing complex Boolean expressions to be built from simpler components. This nesting enables scalable control of increasingly complex gene expression patterns while maintaining precision at each computational level.
3Measurement precision
If orthogonal pairs of hybridizing synthetic nucleic acid constructs are used, then precise and scalable control of gene expression is enabled, but the system complexity increases
Solution Approach 1:
Orthogonal nucleic acid pairs serve as intermediary molecules that mediate between the CRISPR-Cas effector system and the target gene. These synthetic constructs with specific base-pairing properties act as programmable mediators that can be designed to recognize unique sequences, providing precise control while the modular pair design simplifies the overall system architecture compared to traditional biochemical pathways.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise and scalable control of gene expression by generating complex patterns and independent logic gates, allowing for tissue-specific and stimulus-regulated gene activation or repression, enhancing the ability to execute complex genetic programs.
Implementation Method 1
a synthetic CRISPR nucleic acid-tracr nucleic acid (crRNA-tracrRNA) hybrid is formed having a secondary structure comprising a lower stem
Data Source
AI summary
The invention relates to logic-gate-based Type II or Type V CRISPR-Cas constructs and methods for modifying gene expression using the CRISPR-Cas constructs and CRISPR-Cas effector proteins.


